Navigation Links
Statins reduce risks for angioplasty patients

Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.// Angioplasty, an alternative to bypass surgery, allows doctors to open clogged coronary arteries without major surgery by inserting a tiny balloon to the narrowest point and inflating the balloon. But 3 of every 5 patients who go through the procedure will suffer a major setback within 4 years. Some patients suffer heart attacks, others need repeat angioplasty or bypass surgery.

A new study, involving 1,456 patients in 12 countries, has found that cholesterol-lowering drugs could reduce the risk of these complications by 30%, compared with patients taking a placebo. The risk reduced by 40% in patients with more than one clogged artery, and by 45% in patients with diabetes. None of the patients had previously taken the drugs, called statins, and all of them had had their first angioplasty within the previous 8 months.

Statins reduce cholesterol by slowing cholesterol production. Several large studies demonstrated that the drugs prevent heart attacks and heart-disease deaths. Cardiologist Robert Harrington of Duke University said the results are anything but surprising. "It's more evident that statins are good for people with heart disease. we must tell patients undergoing angioplasty that we must start you on a statin."
'"/>




Page: 1

Related medicine news :

1. Statins reduce heart attacks
2. Statins Found To Be Helpful For Patients With Arthritis
3. Long-Term Benefits Of Statins Questioned
4. Statins Not Effective In Treating Calcific Aortic Stenosis
5. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
6. The Effects of Statins Questioned
7. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
8. Study Finds No Link Between Statins And Breast Cancer Risk
9. Statins Reduce Deaths And Strokes After Carotid Surgery
10. Statins reduces cardiovascular risk but no cancer risk.
11. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... Texas (PRWEB) , ... May 26, 2016 , ... ... Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of community ... non-profit that restores, empowers, and renews hope for wounded service members and their families ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our ... PROTECTION TO YOUR HEAD ™”. , “We are proud to introduce Meghan ... football front we have Brian Quick, wide receiver for Los Angeles who was a ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: